सन फार्मास्युटिकल इंडस्ट्रीज

: 524715 | : SUNPHARMA | : INE044A01028

581.80

1.55 (0.27%)

: 18, 17:00

	572.10		27,401
	587.90		610.00
	570.10		423.10
	580.25

581.75

1.80 (0.31%)

: 18, 16:14

	570.55		506,211
	589.05		610.75
	569.80		422.65
	579.95


	0.00	581.80
	0.00	136.00


	581.75	0.00
	113.00	0.00

- सन फार्मास्युटिकल इंडस्ट्रीज

	12,050.03	\|	*	51.53	\|	*	11.29	\|	*	36.23
*	64.51	\|	*	9.02	\|		350.00	\|		0.60
	1.00	\|		1.00	\|		24.19
*

- सन फार्मास्युटिकल इंडस्ट्रीज

Sun Pharma Advanced Research Centre (SP Tandalja,,Akota Road Vadodra 390020 Gujarat
0265-337539
0265-332664
secretarial@sunpharma.com
http://www.sunpharma.com

Link Intime India Pvt. Ltd. C-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)
Mumbai 400078
Maharashtra
022-25960320
022-25960329
rnt.helpdesk@linkintime.co.in
http://www.linkintime.co.in

सन फार्मास्युटिकल इंडस्ट्रीज

सन फार्मास्युटिकल इंडस्ट्रीज ?

सन फार्मास्युटिकल इंडस्ट्रीज

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

| | | | | | 2011 | 2012 | | |

| | | | | | | |

Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in. Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.

Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to 'Risk Factors' in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the 'US Securities Act'), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, 'U.S. persons' (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.